14 episodes

FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (SBIA) podcast provides industry with brief synopses of trending regulatory information.

FDA CDER Small Business and Industry Assistance (SBIA) Chronicles U.S. Food and Drug Administration, Center for Drug Evaluation and Research

    • Health & Fitness

FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (SBIA) podcast provides industry with brief synopses of trending regulatory information.

    Considerations for Drug Products that Contain Nanomaterials

    Considerations for Drug Products that Contain Nanomaterials

    Considerations for Drug Products that Contain Nanomaterials

    • 11 min
    Using Bayesian statistical approaches to advance our ability to evaluate drug products

    Using Bayesian statistical approaches to advance our ability to evaluate drug products

    Using Bayesian statistical approaches to advance our ability to evaluate drug products

    • 7 min
    Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products

    Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products

    Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products

    • 7 min
    The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development

    The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development

    The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development

    • 9 min
    FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds

    FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds

    FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds

    • 11 min
    The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities

    The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities

    The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities

    • 7 min

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
The Dr. John Delony Show
Ramsey Network
Perform with Dr. Andy Galpin
Dr. Andy Galpin
The School of Greatness
Lewis Howes
On Purpose with Jay Shetty
iHeartPodcasts
Passion Struck with John R. Miles
John R. Miles

You Might Also Like